Semasize Plus 1 mg (Semaglutide) Injection 4mg / 3ml (1.34mg/ml) -4 Disposable Needles
Semasize Plus 1 mg (Semaglutide) Injection 4mg / 3ml (1.34mg/ml) -4 Disposable Needles)
Per Unit

Semasize Plus 1 mg (Semaglutide) Injection 4 mg / 3 mL (1.34 mg/mL) – Complete Guide
Introduction
Semasize Plus 1 mg (Semaglutide) Injection is a modern GLP-1 receptor agonist designed to help manage type 2 diabetes and support weight reduction. Supplied in a 4 mg / 3 mL prefilled pen (1.34 mg/mL), it provides multiple weekly doses in a single device. Each pack includes four disposable needles, making it suitable for convenient, hygienic self-administration at home.
Mechanism of Action
Semaglutide mimics the natural glucagon-like peptide-1 (GLP-1) hormone. It enhances glucose-dependent insulin secretion while reducing glucagon release, helping stabilize blood sugar levels. Additionally, it slows gastric emptying and acts on appetite centers in the brain, promoting satiety and reducing food intake. This combination makes it effective for both glycemic control and weight management.
Dosage and Administration
Semasize Plus 1 mg is administered once weekly via subcutaneous injection. Common injection sites include the abdomen, thigh, or upper arm, and sites should be rotated to prevent irritation.
Patients are usually started on a lower dose (such as 0.25 mg or 0.5 mg weekly) before progressing to 1 mg, allowing the body to adapt and reducing gastrointestinal side effects. The prefilled pen system simplifies dosing, while the included disposable needles ensure safe, single-use application.
Key Benefits
- Effective blood sugar control: Helps lower HbA1c levels in people with type 2 diabetes
- Weight loss support: Reduces appetite and caloric intake
- Convenient weekly dosing: Improves adherence compared to daily therapies
- Cardiovascular benefits: May lower the risk of major cardiovascular events in high-risk individuals
Potential Side Effects
The most commonly reported side effects are gastrointestinal, including nausea, vomiting, diarrhea, constipation, and decreased appetite. These effects are generally mild to moderate and tend to subside over time.
Less common but serious risks include pancreatitis, gallbladder disease, and rare allergic reactions. Individuals experiencing severe abdominal pain or persistent symptoms should seek medical attention promptly.
Storage and Handling
Before first use, Semasize Plus should be stored in a refrigerator (2°C to 8°C). After opening, it can typically be kept at room temperature for a limited period, depending on product guidelines. Avoid freezing the medication and protect it from direct sunlight and heat. Always attach a new disposable needle for each injection and dispose of used needles safely.
Who Should Use It
Semasize Plus 1 mg is intended for adults with type 2 diabetes or those prescribed semaglutide for weight management under medical supervision. It is not recommended for individuals with type 1 diabetes or certain medical conditions without professional guidance.
Conclusion
Semasize Plus 1 mg (Semaglutide) Injection offers a practical and effective solution for managing blood glucose and supporting weight loss. With its once-weekly dosing, user-friendly pen design, and proven benefits, it has become a valuable option in modern metabolic care. As with any medication, proper use under healthcare supervision is essential for achieving safe and optimal outcomes.



Support online!


